Early Cancer Detection: Universal Diagnostics' New Blood Test

A blood test uses chemical analysis and data mining to detect early-stage cancer

Innovators: Marko Bitenc and Juan Martínez Barea
Ages: 28 and 48
Co-founders of 12-person biomed startup Universal Diagnostics in Seville, Spain

Form and function: A blood test that combines chemical analysis with an algorithm to identify early-stage cancer with more than 95 percent accuracy, its inventors say.

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE